Global Expansion EvaClean is actively expanding through EU partnerships to deploy its Infection Prevention System across Europe and the Middle East, presenting an opportunity to target regional distributors, healthcare providers, and facilities managers in these markets.

Biofilm Differentiator PurOne and PurTab disinfectants are EPA registered for dry surface biofilm and top-level pathogen kill claims, highlighting a selling point to healthcare facilities and institutions dealing with persistent biofilm challenges.

Navy and biohazard credibility Historical collaborations with the United States Navy and global service providers position EvaClean as a trusted, institutional-grade solution, enabling targeted outreach to large healthcare systems, government facilities, and remediation contractors.

End-to-end solution The integrated approach combining smarter chemistries, electrostatic delivery, and simplified workflows offers a compelling value prop for facilities aiming to reduce outbreaks, human error, and operating costs—key drivers for procurement teams.

Low footprint, high impact With a lean team and revenue under a million, EvaClean seeks partnerships to scale through channel partners, OEMs, and distributors in education, transportation, hospitality, and remediation segments where standardized infection prevention can drive rapid adoption.